Compare OLED & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLED | BIO |
|---|---|---|
| Founded | 1985 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 8.7B |
| IPO Year | 1992 | N/A |
| Metric | OLED | BIO |
|---|---|---|
| Price | $120.02 | $322.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $177.60 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 498.6K | 184.0K |
| Earning Date | 02-19-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.50% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.64 | N/A |
| Revenue | $639,977,000.00 | ★ $2,557,500,000.00 |
| Revenue This Year | $2.50 | $1.62 |
| Revenue Next Year | $10.90 | $2.26 |
| P/E Ratio | $25.86 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $103.70 | $211.43 |
| 52 Week High | $164.29 | $373.69 |
| Indicator | OLED | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | 58.55 |
| Support Level | $119.42 | $316.57 |
| Resistance Level | $126.85 | $328.56 |
| Average True Range (ATR) | 3.22 | 8.27 |
| MACD | 0.17 | 1.43 |
| Stochastic Oscillator | 25.20 | 78.70 |
Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.